Barinthus Biotherapeutics Files Proxy Statement
Ticker: BRNS · Form: DEFA14A · Filed: Apr 25, 2025 · CIK: 1828185
| Field | Detail |
|---|---|
| Company | Barinthus Biotherapeutics PLC. (BRNS) |
| Form Type | DEFA14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, company-name-change
TL;DR
Barinthus Biotherapeutics (formerly Vaccitech) filed its proxy statement on 4/25/25. Standard shareholder meeting stuff.
AI Summary
Barinthus Biotherapeutics plc filed a Definitive Proxy Statement (DEFA14A) on April 25, 2025. The filing concerns the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. Barinthus Biotherapeutics plc was formerly known as Vaccitech plc until April 7, 2021.
Why It Matters
This filing indicates that Barinthus Biotherapeutics plc is preparing for a shareholder meeting, which is a standard corporate governance process for public companies to make important decisions.
Risk Assessment
Risk Level: low — This is a routine proxy statement filing, not indicating any specific new risks or material events.
Key Players & Entities
- Barinthus Biotherapeutics plc (company) — Registrant
- Vaccitech plc (company) — Former company name
- 20250425 (date) — Filing date
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a Definitive Proxy Statement filed with the SEC, used by companies to solicit proxy votes from shareholders for an upcoming meeting.
When was Barinthus Biotherapeutics plc formerly known as?
Barinthus Biotherapeutics plc was formerly known as Vaccitech plc, with the name change occurring on April 7, 2021.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Barinthus Biotherapeutics plc located?
The company's business and mailing address is Unit 6-10, Zeus Building, Rutherford Avenue, Harwell, Didcot, OX11 0DF.
What is the SEC file number for Barinthus Biotherapeutics plc?
The SEC file number for Barinthus Biotherapeutics plc is 001-40367.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 25, 2025 regarding Barinthus Biotherapeutics plc. (BRNS).